EP3013426A2 - Composition à deux phases comprenant de l'acétate de magnésium - Google Patents

Composition à deux phases comprenant de l'acétate de magnésium

Info

Publication number
EP3013426A2
EP3013426A2 EP14739085.0A EP14739085A EP3013426A2 EP 3013426 A2 EP3013426 A2 EP 3013426A2 EP 14739085 A EP14739085 A EP 14739085A EP 3013426 A2 EP3013426 A2 EP 3013426A2
Authority
EP
European Patent Office
Prior art keywords
composition according
weight
composition
phase
chosen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14739085.0A
Other languages
German (de)
English (en)
Inventor
Romain FANFAN
Geoffroy Remaut
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of EP3013426A2 publication Critical patent/EP3013426A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/03—Liquid compositions with two or more distinct layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up

Definitions

  • Two-phase composition comprising magnesium acetate
  • the present invention relates to a composition for topical application, consisting of two separate phases, an aqueous phase and an oily phase, which emulsify readily by shaking and which undergo rapid phase separation after the shaking is stopped.
  • the present invention also relates to the use of the said composition in cosmetics or dermatology, and especially for removing makeup from, cleansing and/or caring for the skin, both bodily and facial skin, and in particular the lips and/or the eyes, and/or for haircare.
  • compositions of this type consisting of two separate phases, especially an aqueous phase and an oily phase which are separate and not emulsified together at rest, are generally referred to as "two-phase compositions". They differ from emulsions in that when at rest, the two phases are separate instead of being emulsified one in the other. Thus, the two phases are separated at rest by a single interface, whereas, in emulsions, one of the phases is dispersed in the other in the form of a multitude of droplets, and the interfaces are therefore multiple, these interfaces generally being stabilized with emulsifying surfactants and/or emulsifying polymers.
  • phase separation The use of two-phase compositions necessitates prior shaking in order to form an extemporaneous emulsion.
  • This emulsion must be of sufficient quality and stability to enable homogeneous application of the two phases, but such that when at rest, the two phases become rapidly separated and regain their initial state, this phenomenon being more commonly known as "phase separation".
  • Rapid phase separation (or demixing) of the two phases after their use is one of the desired qualities of two-phase compositions. Specifically, obtaining rapid phase separation is desirable for various reasons, especially since poor separation of the two phases is perceived by users as being unaesthetic.
  • Document EP 0 603 080 describes the use of alkyldimethylbenzylammonium and especially of benzalkonium chloride as a phase- separation agent, for obtaining rapid phase separation.
  • Document EP 1 514 534 also describes a two-phase composition, containing sodium bicarbonate as phase-separation agent. Nevertheless, it is sought to diversify the type of molecules used as phase- separation agent in order to have available more varied compositions. However, it has proven to be difficult to find phase-separation agents that can afford good phase separation without the formation of foam taking place in the oily phase of the two-phase mixture during shaking. This formation of foam is prohibitive to users.
  • this compound has the advantage of being very well tolerated, including when it is applied to the eyes, which are particularly sensitive to compounds that are liable to be aggressive.
  • Magnesium acetate does not have any aggressiveness and can therefore be advantageously used in the field of cosmetics and in particular in a composition for removing makeup from the eyes.
  • a subject of the invention is a two-phase composition for topical application, comprising an aqueous phase and an oily phase which are separate, and magnesium acetate.
  • composition according to the invention contains a physiologically acceptable medium, i.e. a medium that is compatible with the skin, mucous membranes, the hair and the scalp.
  • composition according to the invention comprises at least an aqueous phase and an oily phase which are separate. These two phases are separate, i.e. they are visible one on top of the other at rest.
  • the two phases may or may not be coloured.
  • Magnesium acetate is the magnesium salt (CH 3 COO " ) 2 Mg 2+ .
  • the amount of magnesium acetate may range, for example, from 0.001 % to 5% by weight, preferably from 0.005% to 1 % by weight, better still from 0.005% to 0.5% by weight and even better still from 0.005% to 0.2% by weight, relative to the total weight of the composition.
  • the amount of magnesium acetate is less than or equal to 0.5% by weight relative to the total weight of the composition.
  • magnesium acetate it is possible to add, in addition to magnesium acetate, another salt, for instance sodium chloride, which has no effect on the phase separation, but which is used as adjuvant in a composition for removing makeup from the eyes in order for the composition to have an osmotic pressure close to that of tears.
  • the amount of salt(s) other than magnesium acetate may range, for example, from 0 to 5% by weight, preferably from 0.1 % to 2% by weight and better still from 0.5% to 1 % by weight relative to the total weight of the composition.
  • the weight ratio between the aqueous phase and the oily phase ranges from 10/90 to 90/10, preferably from 25/75 to 90/10, even more preferentially from 30/70 to 70/30 and better still from 40/60 to 60/40.
  • the aqueous phase generally represents from 10% to 90% by weight, preferably from 25% to 90% by weight, even more preferentially from 30% to 70% by weight and better still from 40% to 60% by weight relative to the total weight of the composition.
  • This weight ratio is adjusted according to the desired cosmeticity and so that the composition has a freezing point of less than 4°C.
  • the aqueous (or hydrophilic) phase of the composition according to the invention advantageously comprises water.
  • the water used may be sterile demineralized water and/or a floral water such as rose water, cornflower water, camomile water or lime blossom water, and/or a natural spring water or mineral water, for instance: Vittel water, Vichy basin water, Uriage water, Roche Posay water, Bourboule water, Enghien-les-Bains water, Saint Gervais-les-Bains water, Neris-les-Bains water, Allevar-les-Bains water, Digne water, Maizieres water, Neyrac-les-Bains water, Lons-le-Saunier water, Eaux Bonnes water, Rochefort water, Saint Christau water, Fumades water, Tercis-les-bains water and Avene water.
  • the aqueous phase may also comprise reconstituted spring water, i.e. a water containing trace elements such as zinc, copper, magnesium, etc., reconstituting
  • the aqueous (or hydrophilic) phase of the composition according to the invention may also contain any water-soluble or water-dispersible additive.
  • Water-soluble additives that may especially be mentioned are polyols.
  • the term "polyol” should be understood as meaning any organic molecule comprising at least two free hydroxyl groups. Examples of polyols that may be mentioned include glycerol, glycols, for instance butylene glycol, propylene glycol, isoprene glycol, dipropylene glycol, hexylene glycol, polyethylene glycols, polypropylene glycol, sorbitol, sugars such as glucose, xylitol, trehalose, xylose, mannose or rhamnose, and mixtures thereof.
  • the polyol(s) are chosen from glycerol, butylene glycol, propylene glycol, caprylyl glycol, propanediol, dipropylene glycol and hexylene glycol. More preferentially, the polyol is glycerol.
  • the polyols may be present in the composition according to the invention in a content ranging from 0.1 % to 60% by weight, preferably from 1 % to 50% by weight, better still from 2% to 30% by weight and even better still from 3% to 20% by weight relative to the total weight of the composition.
  • Water-soluble additives that may also be mentioned include primary alcohols, i.e. an alcohol comprising from 1 to 6 carbon atoms, such as ethanol and isopropanol. It is preferably ethanol. This alcohol may be present in an amount that is, for example, less than or equal to 40% by weight and preferably ranging from 0.1 % to 20% by weight relative to the total weight of the composition. The addition of such an alcohol may especially be suitable when the composition according to the invention is used as a product for the body or the hair.
  • primary alcohols i.e. an alcohol comprising from 1 to 6 carbon atoms, such as ethanol and isopropanol. It is preferably ethanol.
  • This alcohol may be present in an amount that is, for example, less than or equal to 40% by weight and preferably ranging from 0.1 % to 20% by weight relative to the total weight of the composition.
  • the addition of such an alcohol may especially be suitable when the composition according to the invention is used as a product for the body or the hair.
  • the aqueous phase comprises at least one aqueous-phase opacifier.
  • aqueous-phase opacifier means any additive for opacifying the aqueous phase into which it is added, for example an additive which, when added to a transparent medium, would lead to a translucent to opaque medium.
  • the transparency of a composition may be measured by its turbidity, and the NTU (nephelometric turbidity units) are the units for measuring the turbidity of a composition.
  • the turbidity measurement may be performed, for example, with a model 21 OOP turbidimeter from the Hach Company, the tubes used for the measurement being referenced AR397A cat 24347-06. The measurements are performed at room temperature (20°C to 25°C).
  • the composition of the invention has a turbidity generally ranging from 2 to 300 NTU and preferably from 5 to 200 NTU.
  • the composition is said to be transparent when it has a turbidity of less than or equal to 20 NTU. It is said to be translucent when its turbidity is between 20 and 300 NTU. It is said to be opaque when its turbidity is greater than or equal to 300 NTU.
  • the opacifier(s) that may be used in the context of the invention are chosen, for example, from (Ci-C 6 )alkylcelluloses; latices, for instance polymers or copolymers based on styrene or crosslinked copolymers based on acrylic acid or even based on methacrylic acid and C1-C4 alkyl acrylate; esters of polyols containing at least two carbon atoms, which are optionally oxyethylenated, and of fatty acids; C10-C30 fatty acid alkanolamides and esters of Ci 0-C30 fatty acids and of C10-C30 fatty acid alkanolamides.
  • the opacifier(s) may be chosen from alkylcelluloses, the alkyl residue of which comprises between 1 and 6 carbon atoms and preferably between 1 and 3 carbon atoms, preferably ethylcellulose.
  • the alkylcellulose(s) are cellulose alkyl ethers comprising a chain consisting of ⁇ - anhydroglucose units linked together via acetal bonds.
  • Each anhydroglucose unit contains three replaceable hydroxyl groups, all or some of these hydroxyl groups being able to react according to the following reaction:
  • the alkylcellulose(s) are chosen from methylcellulose, ethylcellulose and propylcellulose.
  • the alkylcellulose is ethylcellulose. It is a cellulose ethyl ether.
  • the ethylcellulose polymers used in a cosmetic composition according to the invention are preferentially polymers with a degree of substitution with ethoxy groups ranging from 2.5 to 2.6 per anhydroglucose unit, in other words comprising a content of ethoxy groups ranging from 44% to 50%.
  • the alkylcellulose (preferably ethylcellulose) is used in a composition of the invention in the form of particles dispersed in an aqueous phase, like a dispersion of latex or pseudolatex type.
  • a dispersion of latex or pseudolatex type like a dispersion of latex or pseudolatex type.
  • the techniques for preparing these latex dispersions are well known to those skilled in the art.
  • the product sold by the company FMC Biopolymer under the name Aquacoat ECD-30 which consists of a dispersion of ethylcellulose in a proportion of about 26.2% by weight in water and stabilized with sodium lauryl sulfate and cetyl alcohol, is most particularly suitable for use as an aqueous dispersion of ethylcellulose.
  • the opacifier(s) may be chosen from latices.
  • the latices that may be used in the context of the invention may be nonionic or ionic, in particular anionic.
  • the term "latices” means colloidal dispersions in an aqueous or organic liquid phase of insoluble polymer particles generally obtained by suspension or emulsion polymerization or copolymerization of monomers according to well-known processes of the prior art.
  • aqueous dispersions that may be used according to the invention may originate from the condensation of monomer units, giving, for example, nonionic polymers such as polyesters, polyamides, polyurethanes or polyethers.
  • polystyrenes such as the product sold under the name Modarez OS-197 by the company Synthron, and which is a polystyrene as a 40% emulsion in water.
  • the latex or latices When the latex or latices are anionic, they generally contain anionic functional groups that are provided either by polymerization or copolymerization of anionic monomers, via usual processes known to those skilled in the art, or by combination of the anionic free radical derived from the reaction initiator with the monomer(s) under consideration during the initiation of polymerization of the said monomers, or alternatively by juxtaposition of these two synthetic processes, or alternatively by introducing end groups via a chain-transfer reaction in the second process using a reaction initiator.
  • the process using reaction initiators is described in particular in the article by R.M. Fitch Preparation and Characterization of Charge stabilized Polymer Colloids in Polyelectrolytes and their applications, 51 -69 by D. Reider publishing company.
  • the latices that may be used in the context of the invention may especially result from the polymerization or copolymerization of various monomers such as styrene, butadiene, ethylene, propylene, vinyltoluene, vinyl propionate, vinyl alcohol, acrylonitrile, chloroprene, vinylidene chloride, vinyl acetate, urethanes, isoprene, isobutene, vinyl chloride, and acrylic or methacrylic, vinylacetic, maleic, crotonic or itaconic acid esters or amides, vinyl ether, vinylpyrrolidone or vinylimidazole, used alone or as a mixture with one or more of the following ion-generating monomers: acrylic, methacrylic, itaconic, maleic, crotonic, para-styrenesulfonic, vinylsulfonic, 2-methacryloyloxyethylsulfonic and 2-acrylamido-2- methylpropylsul
  • the latices may also be obtained by polymerization or copolymerization of the ion- generating monomers mentioned previously.
  • the latices obtained in accordance with the second abovementioned process result from the use of initiators chosen from redox systems, peroxides, perphosphates, percarbonates, persulfates, peroxidized organic acids, for instance peracetic acid, or the persulfate- bisulfite-iron mixture.
  • initiators chosen from redox systems, peroxides, perphosphates, percarbonates, persulfates, peroxidized organic acids, for instance peracetic acid, or the persulfate- bisulfite-iron mixture.
  • the functional monomers used in the case of a chain-transfer reaction are chosen from organic thioacids, for instance mercaptoacetic acid.
  • anionic latices that may be used in accordance with the invention, mention may be made in particular of the products sold under the following trade names: Primal ASE 95, Primal WL-91 K, Primal TR-934 TK and Primal HA-8 by the company Rohm & Haas and which are acrylic aqueous emulsions comprising between 20% and 50% of solids; Appretan 680 by the company Clariant and which is a 50% dispersion of styrene/acrylic acid copolymer; Acrymul AM 123 R by the company Protex and which is a 45% aqueous dispersion of acrylic copolymer; Lucidene 604 by the company Morton Salt and which is an emulsion of a styrene/acrylic acid copolymer; Syntran 5760 CG by the company Interpolymer Corporation and which is an acrylate/ammonium methacrylate/styrene copolymer in aqueous dispersion; Chemigum Late
  • the latices that may be used in the context of the invention are styrene/acrylic acid copolymers.
  • the styrene/acrylic copolymer is in the form of particles in aqueous dispersion, i.e. in the form of particles as a stable dispersion in an aqueous medium.
  • the copolymer particles are spherical or virtually spherical particles preferably having a number-average size ranging from 0.1 to 5 ⁇ .
  • aqueous medium means herein both a medium containing only water and a medium comprising water and a water-soluble solvent such as a lower alcohol comprising 1 to 6 carbon atoms or a glycol.
  • the styrene/acrylic copolymer is obtained by polymerization of styrene with at least one monomer chosen from acrylic acid, methacrylic acid, an acrylic acid ester and a methacrylic acid ester, the copolymer obtained being optionally crosslinked.
  • the copolymer may or may not be neutralized with a mineral base such as ammonia or with an organic base.
  • styrene/acrylic copolymer dispersions that may be used in the composition of the invention, examples that may be mentioned include those sold under the name Ropaque OP-96 (aqueous dispersion containing 31 % copolymer neutralized with ammonia), Ropaque OP-3000 (aqueous dispersion containing 37% copolymer) and Acudyne 290 (aqueous dispersion containing 40% copolymer) by the company Rohm & Haas, Lucidene 604 by the company Morton Salt, which is an emulsion of a styrene/acrylic acid copolymer.
  • Ropaque OP-96 aqueous dispersion containing 31 % copolymer neutralized with ammonia
  • Ropaque OP-3000 aqueous dispersion containing 37% copolymer
  • Acudyne 290 aqueous dispersion containing 40% copolymer
  • CTFA name Trideceth-7 polyethylene glycol (7 OE) tridecyl ether
  • the latex or latices may also be chosen from crosslinked copolymers of methacrylic acid and of C1-C4 alkyl acrylate.
  • Methacrylic acid is preferably present in amounts ranging from 20% to 80% by weight, more particularly from 25% to 70% by weight and even more particularly from 35% to 60% by weight relative to the total weight of the copolymer.
  • the alkyl acrylate is preferably present in amounts ranging from 15% to 80% by weight, more particularly from 25% to 75% by weight and even more particularly from 40% to 65% by weight relative to the total weight of the copolymer. It is chosen especially from methyl acrylate, ethyl acrylate and butyl acrylate and more particularly ethyl acrylate.
  • the copolymers are partially or totally crosslinked with at least one standard crosslinking agent.
  • the crosslinking agents are especially polyunsaturated compounds, in particular ethylenically polyunsaturated compounds. These compounds are especially polyalkenyl ethers of sucrose or of polyols, diallyl phthalates, divinylbenzene, allyl (meth)acrylate, ethylene glycol di(meth)acrylate, methylenebisacrylamide, trimethylolpropane tri(meth)acrylate, diallyl itaconate, diallyl fumarate, diallyl maleate, zinc (meth)acrylate, and castor oil or polyol derivatives manufactured from unsaturated carboxylic acids.
  • crosslinking agent use may also be made of unsaturated monomeric compounds comprising a reactive group that is capable of reacting with an unsaturation to form a crosslinked copolymer.
  • the content of crosslinking agent generally ranges from 0.01 % to 5% by weight, preferably from 0.03% to 3% by weight and even more particularly from 0.05% to 1 % by weight relative to the total weight of the copolymer.
  • the copolymer of the invention may especially be in the form of a dispersion in water.
  • the number-average size of the copolymer particles in the dispersion is generally between 10 and 500 nm, preferably between 20 and 200 nm and more preferentially from 50 to 150 nm.
  • copolymers are described especially in patent application WO 01/76552.
  • the opacifier(s) may be chosen from esters of polyols containing at least two carbon atoms, which are optionally oxyethylenated, and of fatty acids.
  • fatty acid means a carboxylic acid comprising a linear or branched, saturated or unsaturated hydrocarbon-based chain comprising from 10 to 30 carbon atoms, preferably from 14 to 24 carbon atoms and better still from 16 to 18 carbon atoms in the longest carbon chain, optionally substituted with one or more hydroxyl radicals.
  • the hydrocarbon-based chain is an alkyl or alkenyl chain, comprising one or more optionally conjugated ethylenic unsaturations, which is optionally substituted with one or more hydroxyl radicals.
  • the polyol(s) preferably comprise between 2 and 16 carbon atoms, preferably between 2 and 4 carbon atoms, and optionally on average from 2 to 15 mol of ethylene oxide.
  • esters of polyols containing at least two carbon atoms, which are optionally oxyethylenated, and of fatty acids may be chosen especially from ethylene glycol, polyethylene glycol, glycerol, propylene glycol and polyglyceryl monostearates and distearates, and ethylene glycol, polyethylene glycol, glycerol, propylene glycol and polyglyceryl monopalmitates and dipalmitates, and mixtures thereof.
  • the polyethylene glycol and polyglycerol esters comprise from 2 to 150 and preferably from 2 to 15 ethylene glycol or glycerol groups.
  • Use is preferably made of ethylene glycol monostearates and distearates, diethylene glycol monostearates and distearates, triethylene glycol monostearates and distearates, ethylene glycol monopalmitates and dipalmitates, or glyceryl monopalmitates and dipalmitates.
  • Use may be made, for example, of the glycol distearate sold under the name Tegin BL 315 by the company Evonik-Goldschmidt. Mention may also be made of the glycol palmitate sold under the name Lanol P Ecailles by the company SEPPIC.
  • the Cio-C 30 fatty acid alkanolamides may be chosen from fatty acid alkanolamides in which the alkanolamine-based part is of C1-C4. It should be noted that the alkanolamine from which the compounds of this family are derived may be monoethanolamines or diethanolamines. Examples of compounds of this family that are suitable for use include, inter alia, stearic acid monoethanolamide, stearic acid diethanolamide, stearic acid monoisopropanolamide and stearic acid monoethanolamide stearate.
  • the C10-C30 fatty acid esters of C10-C30 fatty acid alkanolamides are chosen from C10-C30 esters of C10-C30 alkanolamides in which the C10-C30 radicals are saturated or unsaturated, linear or branched radicals.
  • Examples of such compounds that may be mentioned include distearate stearamide diethanolamide and stearate stearamide monoethanolamide, and more particularly the product sold under the name Cerasynt D by the company ISP.
  • the opacifier(s) present in the composition in accordance with the invention are chosen from latices.
  • the latex or latices are chosen from styrene-based polymers or copolymers or crosslinked copolymers of methacrylic acid and of C1-C4 alkyl acrylate such as those defined previously. Even more preferentially, the latex or latices are chosen from styrene- based polymers or copolymers.
  • the opacifier(s), when they are present in the composition, generally represent from 0.01 % to 5% by weight, preferably from 0.05% to 1 % by weight and better still from 0.05% to 0.5% by weight relative to the total weight of the aqueous phase.
  • the nature and amount of the opacifier(s) are chosen such that the composition in accordance with the invention is opaque, i.e. such that its turbidity value is greater than or equal to 300 NTU.
  • the opacifier(s) are chosen from styrene-based polymers or copolymers and their concentration ranges from 0.01 % to 5%.
  • the oily phase generally represents from 10% to 90% by weight, preferably from 20% to 75% by weight, even more preferentially from 30% to 70% by weight and better still from 40% to 60% by weight relative to the total weight of the composition.
  • the oily phase of the composition according to the invention may comprise one or more oils, these oils possibly being chosen from hydrocarbon-based, mineral, plant and synthetic oils, or alternatively silicone oils. It may also comprise liposoluble or lipodispersible additives.
  • hydrocarbon-based oil means an oil formed essentially from, or even consisting of, carbon and hydrogen atoms, and possibly oxygen and nitrogen atoms, and containing no silicon or fluorine atoms; it may contain ester, ether, amine or amide groups.
  • hydrocarbon-based oils that may be used in the composition of the invention, examples that may be mentioned include:
  • esters and ethers especially of fatty acids, for instance the oils of formulae R 1 COOR 2 and R 1 OR 2 in which R 1 represents a fatty acid residue containing from 8 to 29 carbon atoms and R 2 represents a branched or unbranched hydrocarbon-based chain containing from 3 to 30 carbon atoms, for instance purcellin oil, isononyl isononanoate, isopropyl myristate, isopropyl palmitate, 2-ethylhexyl palmitate, 2-octyldodecyl stearate, 2- octyldodecyl erucate or isostearyl isostearate; hydroxylated esters, for instance isostearyl lactate, octyl hydroxystearate, octyldodecyl hydroxystearate, diisostearyl malate, triisocetyl citrate, and fatty alkyl heptanoates,
  • oils of plant origin such as perhydrosqualene, liquid triglycerides of fatty acids containing from 4 to 10 carbon atoms, for instance heptanoic or octanoic acid triglycerides, or alternatively, for example, sunflower oil, maize oil, soybean oil, marrow oil, grapeseed oil, sesame seed oil, hazelnut oil, apricot kernel oil, macadamia oil, arara oil, coriander oil, castor oil, avocado oil, caprylic/capric acid triglycerides, jojoba oil, shea butter oil, meadowfoam oil and argan oil;
  • - fatty alcohols that are liquid at room temperature, containing from 8 to 26 carbon atoms, for instance octyldodecanol, 2-butyloctanol, 2-hexyldecanol, 2-undecylpentadecanol or oleyl alcohol.
  • silicon oil means an oil containing at least one silicon atom, and especially containing Si-0 groups.
  • the silicone oil(s) may be volatile or non-volatile.
  • volatile refers to a compound that can evaporate on contact with the skin in less than one hour, at room temperature and atmospheric pressure.
  • the volatile oil is a volatile cosmetic oil, which is liquid at room temperature, especially having a non-zero vapour pressure, at room temperature and atmospheric pressure, in particular having a vapour pressure ranging from 0.13 Pa to 40 000 Pa (10 "3 to 300 mmHg), preferably ranging from 1 .3 Pa to 13 000 Pa (0.01 to 100 mmHg) and preferentially ranging from 1.3 Pa to 1300 Pa (0.01 to 10 mmHg).
  • volatile silicone oils examples include cyclopolydimethylsiloxanes (INCI name: cyclomethicone), such as cyclopentasiloxane, cyclohexasiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane; linear silicones such as heptamethylhexyltrisiloxane, heptamethyloctyltrisiloxane, hexamethyldisiloxane, octamethyltrisiloxane, decamethyltetrasiloxane and dodecamethylpentasiloxane.
  • cyclopolydimethylsiloxanes such as cyclopentasiloxane, cyclohexasiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane
  • the volatile silicone oil is chosen from cyclopentasiloxane and cyclohexasiloxane.
  • Non-volatile silicone oils that may be mentioned include silicone oils such as polymethylsiloxanes, especially PDMS, and phenyl polymethylsiloxanes such as phenyl trimethicones, phenyl dimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyl dimethicones, diphenylmethyldiphenyltrisiloxanes, 2-phenylethyltrimethyl siloxysilicates and polymethylphenylsiloxanes; polysiloxanes modified with fatty acids, fatty alcohols or polyoxyalkylenes, and mixtures thereof.
  • silicone oils such as polymethylsiloxanes, especially PDMS, and phenyl polymethylsiloxanes such as phenyl trimethicones, phenyl dimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyl dimethicones, diphenylmethyldiphen
  • the amount of silicone oil(s) is less than 80% and preferably less than 20% by weight relative to the total weight of the oily phase.
  • the oil(s) are chosen from hydrocarbon-based oils.
  • the oil(s) are chosen from fatty acid esters such as isopropyl palmitate, fatty alcohol ethers, mineral oils such as liquid petroleum jelly, fatty alcohols that are liquid at room temperature and liquid fatty acid triglycerides.
  • the oil(s) are chosen from fatty acid esters such as isopropyl palmitate, fatty alcohols that are liquid at room temperature and liquid fatty acid triglycerides.
  • the oils may optionally consist solely of volatile oils.
  • the two-phase composition according to the invention may optionally comprise one or more surfactants in one or the other of the phases, especially when it is used as a makeup-removing or cleansing composition, since the presence of a surfactant makes it possible both to obtain good makeup removal for makeup compositions and especially mascaras, and also to be free of a greasy sensation during the makeup removal.
  • the composition of the invention may also be free of surfactant, and, if it contains any, the amount of surfactant should be such that the composition remains at rest in the form of two separate phases and not in the form of an emulsion.
  • composition of the invention contains a surfactant
  • a surfactant it may be of the anionic, nonionic or amphoteric type, but it is preferably of the nonionic type, and it is preferably present in the aqueous phase of the composition.
  • the amount of surfactant(s) as active material may range, for example, from 0.001 % to 5% by weight, preferably from 0.002% to 1 % by weight and better still from 0.01 % to 0.5% by weight relative to the total weight of the composition.
  • nonionic surfactants those that are particularly preferred are:
  • R represents a linear or branched, saturated or unsaturated alkyl radical comprising from 6 to 30 carbon atoms
  • G represents a reduced sugar comprising 5 or 6 carbon atoms
  • x is a value ranging from 1 to 15;
  • the composition when the composition contains a surfactant, it contains at least one nonionic surfactant and preferably at least one alkylpolyglycoside.
  • the alkylpolyglycosides preferably used in the composition according to the present invention are compounds of formula (I) in which R more particularly denotes an alkyl radical comprising from 6 to 30 carbon atoms and preferably from 8 to 16 carbon atoms, G denotes glucose, fructose or galactose, and x is a value ranging from 1 to 4 and more particularly from 1 to 3.
  • the alkylpolyglycoside used in the composition of the invention is an alkylpolyglucoside, i.e. a compound of formula (I) in which G denotes glucose and x is a value ranging from 1.2 to 3.
  • alkylpolyglucosides examples include decylglucoside (Alkyl- C9/C1 1 -polyglucoside (1 .4)) for instance the product sold under the name Mydol 10 by the company Kao Chemicals, the product sold under the names Plantaren 2000 UP and Plantacare 2000 UP by the company Henkel, and the product sold under the name Oramix NS 10 by the company SEPPIC; caprylyl/capryl glucoside, for instance the product sold under the name Oramix CG 1 10 by the company SEPPIC or under the name Lutensol GD 70 by the company BASF; lauryl glucoside, for instance the products sold under the names Plantaren 1200 N and Plantacare 1200 by the company Henkel; cocoyl glucoside, for instance the product sold under the name Plantacare 818/UP by the company Henkel; and mixtures thereof.
  • decylglucoside Alkyl- C9/C1 1 -polyglucoside
  • composition according to the invention may also contain conventional cosmetic adjuvants or additives, which will be in one or other phase depending on their hydrophilic or lipophilic nature, for instance fragrances, preserving agents and bactericides, dyes, softeners, buffers, humectants, UV-screening agents (or sunscreens), electrolytes such as sodium chloride as indicated above, or a pH regulator (for example citric acid or sodium hydroxide), and mixtures thereof.
  • fragrances for instance fragrances, preserving agents and bactericides, dyes, softeners, buffers, humectants, UV-screening agents (or sunscreens), electrolytes such as sodium chloride as indicated above, or a pH regulator (for example citric acid or sodium hydroxide), and mixtures thereof.
  • preserving agents and bactericides dyes, softeners, buffers, humectants
  • UV-screening agents or sunscreens
  • electrolytes such as sodium chloride as indicated above, or a pH regulator (for example citric acid or
  • Preserving agents that may be used include any preserving agent usually used in the fields under consideration, for instance parabens, phenoxyethanol, chlorhexidine gluconate and polyhexamethylene biguanide hydrochloride (CTFA name: Polyaminopropyl biguanide).
  • CTFA name Polyaminopropyl biguanide
  • the composition contains polyhexamethylene biguanide hydrochloride, alone or as a mixture with other preserving agents.
  • a bactericide that may be used is a glyceryl mono(C 3 -C 9 )alkyl or (C 3 - C 9 )alkenyl ether, the manufacture of which is described in the literature, in particular in E. Baer, H.O.L. Fischer - J. Biol. Chem. 140-397-1941.
  • glyceryl mono(C 3 - C 9 )alkyl or (C 3 -C 9 )alkenyl ethers use is preferably made of 3-[(2-ethylhexyl)oxy]-1 ,2- propanediol, 3-[(heptyl)oxy]-1 ,2-propanediol, 3-[(octyl)oxy]-1 ,2-propanediol and 3- [(allyl)oxy]-1 ,2-propanediol.
  • a glyceryl mono(C 3 -C 9 )alkyl ether that is more particularly preferred according to the present invention is 3-[(2-ethylhexyl)oxy]-1 ,2-propanediol, sold by the company Schulke & Mayr G.m.b.H. under the trade name Sensiva SC 50 (INCI name: Ethylhexylglycerin).
  • softeners mention may be made in particular of allantoin and bisabolol, planktons, and certain plant extracts, such as rose extracts and melilot extracts.
  • the active agent(s) that may be present depend on the final purpose of the composition.
  • active agents that may be used in the composition of the invention especially when it is a skincare composition, examples that may be mentioned include enzymes (for example lactoperoxidase, lipase, protease, phospholipase, cellulases); flavonoids such as isoflavones; moisturizers such as protein hydrolysates; sodium hyaluronate; antiinflammatory agents; oligomeric proanthocyanidins; vitamins such as vitamin A (retinol), vitamin E (tocopherol), vitamin C (ascorbic acid), vitamin B5 (panthenol), vitamin B3 (niacinamide), derivatives of these vitamins (in particular esters) and mixtures thereof; urea; caffeine; depigmenting agents such as kojic acid, hydroquinone and caffeic acid; salicylic acid and derivatives thereof; ohydroxy acids, such as lactic acid and glycolic acid and derivatives thereof; reti
  • the UV-screening agents may be present in the composition according to the invention especially when it is intended for antisun protection. These screening agents may especially be organic screening agents, and they may be present in an active-material amount ranging from 0.01 % to 20% by weight of active material, preferably from 0.1 % to 15% by weight and better still 0.2% to 10% by weight relative to the total weight of the composition.
  • UV-A-active and/or UV-B-active organic screening agents which may be added to the composition of the invention
  • examples that may be mentioned include derivatives bearing a sulfonic function, such as sulfone or sulfonate derivatives of benzylidenecamphor, benzophenone or phenylbenzimidazole, more particularly benzylidenecamphor derivatives, for instance benzene-1 ,4-bis(3-methylidenecamphor-10- sulfonic acid), (INCI name: Terephthalylidenedicamphorsulfonic acid) manufactured under the name Mexoryl SX by the company Chimex, and 4'-sulfo-3-benzylidenecamphor (INCI name: Benzylidenecamphorsulfonic acid) manufactured under the name Mexoryl SL by the company Chimex, 2-[4-(camphormethylidene)phenyl]benzimidazole-5-sulfonic acid, phenyliden
  • compositions described above may be conditioned, in a known manner, in a bottle with a single compartment. The user must then shake the bottle before pouring its contents onto a pad of cotton wool. It may also be envisaged for the two phases of the composition to be introduced into two independent compartments of the same bottle, a system being provided for mixing them together at the time of dispensing. Such devices are described, for example, in documents EP-A-497 256 and FR-A-2 697 233.
  • composition according to the invention may be used for any topical application, and may especially constitute a cosmetic or dermatological composition. It may in particular be used for caring for, cleansing and/or removing makeup from the skin, the lips and/or the eyes, and also as a haircare composition.
  • a subject of the invention is also the cosmetic use of a cosmetic composition as defined above, for caring for, removing makeup from and/or cleansing the skin, the lips and/or the eyes, and/or for haircare.
  • a subject of the present invention is also a cosmetic process for removing makeup from, cleansing and/or caring for the skin, the lips and/or the eyes, characterized in that a cosmetic composition as defined above is applied to the skin, the lips and/or the eyes.
  • a subject of the present invention is also a cosmetic haircare process, characterized in that a cosmetic composition as defined above is applied to the hair.
  • the composition is a composition for caring for bodily and/or facial skin.
  • compositions according to the invention are given as illustrations with no limiting nature.
  • the amounts therein are given as weight percentages of starting material, unless otherwise mentioned.
  • the names of the compounds are given as the chemical names or the INCI names.
  • Example 1 The following composition is prepared.
  • Citric acid monohydrate 0.005%
  • the two-phase composition thus obtained consisting of two separate immiscible phases, after shaking and extemporaneous and transient formation of an emulsion, undergoes rapid phase separation into two phases, without formation of foam.
  • Procedure The process is performed entirely without heating, with dissolution of the starting materials of A and then dispersion of B in A, followed by addition of the dilute magnesium acetate, before pH adjustment.
  • the two-phase composition thus obtained consisting of two separate immiscible phases, after shaking and extemporaneous and transient formation of an emulsion, undergoes rapid phase separation into two phases, without formation of foam.
  • Example 3 two-phase mixture without opacifier
  • composition C (comparative)
  • a composition comprising a residual foam in the fatty phase and having a lower demixing speed and a non-planar interface.
  • Example 5 two-phase mixture with opacifier Fatty phase (20%):
  • the two-phase composition thus obtained consisting of two separate immiscible phases, after shaking and extemporaneous and transient formation of an emulsion, undergoes rapid phase separation into two phases, without formation of foam.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne une composition à deux phases qui est destinée à une application topique et comprend une phase aqueuse et une phase huileuse distinctes, et de l'acétate de magnésium, le rapport pondéral entre la phase aqueuse et la phase huileuse allant de préférence de 10/90 à 90/10. La présence d'acétate de magnésium permet d'obtenir une séparation de phase satisfaisante des deux phases après agitation, et d'éviter la formation de mousse dans la phase huileuse pendant l'agitation. L'invention concerne également l'utilisation de ladite composition dans le domaine cosmétique, particulièrement pour éliminer un maquillage de la peau, des lèvres et/ou des yeux, les nettoyer et/ou les soigner, ou pour les soins capillaires.
EP14739085.0A 2013-06-28 2014-06-30 Composition à deux phases comprenant de l'acétate de magnésium Withdrawn EP3013426A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1356307A FR3007638B1 (fr) 2013-06-28 2013-06-28 Composition biphase comprenant de l'acetate de magnesium
PCT/EP2014/063867 WO2014207259A2 (fr) 2013-06-28 2014-06-30 Composition à deux phases comprenant de l'acétate de magnésium

Publications (1)

Publication Number Publication Date
EP3013426A2 true EP3013426A2 (fr) 2016-05-04

Family

ID=49667277

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14739085.0A Withdrawn EP3013426A2 (fr) 2013-06-28 2014-06-30 Composition à deux phases comprenant de l'acétate de magnésium

Country Status (5)

Country Link
EP (1) EP3013426A2 (fr)
JP (1) JP2016523279A (fr)
CN (1) CN105473184A (fr)
FR (1) FR3007638B1 (fr)
WO (1) WO2014207259A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7107620B2 (ja) * 2016-11-25 2022-07-27 エルブイエムエイチ レシェルシェ 水性化粧料
FR3067248B1 (fr) * 2017-06-09 2019-10-25 L'oreal Composition biphase comprenant un sel de chlorhexidine
CN112218609A (zh) * 2018-05-30 2021-01-12 莱雅公司 用于局部施用的两相组合物
DE102018219931A1 (de) * 2018-11-21 2020-05-28 Beiersdorf Aktiengesellschaft Ölhaltige Gesichtspflegezubereitung
CN114727911B (zh) * 2019-11-29 2023-10-20 莱雅公司 用于局部施用的两相组合物
FR3104963B1 (fr) * 2019-12-20 2022-07-15 Oreal Composition biphase comprenant une phase aqueuse comprenant un ou des polyols a une teneur allant de 5% a 30% en poids et une phase huileuse comprenant des huiles non siliconees
CN116096340A (zh) * 2020-07-31 2023-05-09 莱雅公司 用于护理角蛋白材料的组合物及其使用方法
KR102525475B1 (ko) * 2020-12-09 2023-04-26 애경산업(주) 현탁성 클렌징 화장료 조성물
CN116744888A (zh) * 2021-01-12 2023-09-12 莱雅公司 用于清洁角蛋白材料和/或从角蛋白材料上卸妆的双相组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0047804A1 (fr) * 1980-09-15 1982-03-24 Unilever Plc Emulsions eau-dans-huile et procédé pour leur préparation
US6649174B2 (en) * 1998-05-07 2003-11-18 E-L Management Corp. Dual phase cosmetic composition
DE10235422A1 (de) * 2002-08-02 2004-02-12 Beiersdorf Ag Kosmetische Zubereitungen mit zwei Phasen
FR2847468B1 (fr) * 2002-11-26 2006-02-24 Oreal Composition biphase transparente pour application topique et son utilisation cosmetique
US20050075265A1 (en) * 2003-09-12 2005-04-07 L'oreal Two-phase compositions and uses thereof
FR2859626B1 (fr) * 2003-09-12 2006-01-27 Oreal Composition biphase et ses utilisations dans le domaine cosmetique
FR2864893B1 (fr) * 2004-01-12 2006-02-10 Oreal Composition biphase et ses utilisations dans le domaine cosmetique
ES2397559T3 (es) * 2009-03-09 2013-03-07 Unilever Nv Una composición cosmética para aclarar la piel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2014207259A3 *

Also Published As

Publication number Publication date
FR3007638B1 (fr) 2015-08-07
JP2016523279A (ja) 2016-08-08
WO2014207259A2 (fr) 2014-12-31
CN105473184A (zh) 2016-04-06
WO2014207259A3 (fr) 2015-04-09
FR3007638A1 (fr) 2015-01-02

Similar Documents

Publication Publication Date Title
US10016348B2 (en) Two-phase composition comprising a fatty acid ester of sugar or a liquid alkyl polyglucoside, with an HLB < 8, and a C8-C18 branched alkane
WO2014207259A2 (fr) Composition à deux phases comprenant de l'acétate de magnésium
WO2010069995A1 (fr) Composition à deux phases transparentes sans silicone
EP2872112A2 (fr) Composition à deux phases contenant un alkylpolyglucoside et un ester dont le point de fusion est inférieur à 10 °c
WO2010026140A1 (fr) Procédé d’élimination ou de nettoyage de maquillage au moyen d'un c7-c17 alcane linéaire volatil
US20060210612A1 (en) Make-up-removing article
KR20160008548A (ko) 실리콘 오일 및 폴리메틸메타크릴레이트 입자를 포함하는 미용 조성물
JP2006241150A (ja) 化粧メイクアップ除去製品
JP2004285047A (ja) 局所適用のための透明な二相組成物
US20050075265A1 (en) Two-phase compositions and uses thereof
FR2971421A1 (fr) Composition biphase
JP4031473B2 (ja) ２相組成物およびその化粧料としての使用
US7459149B2 (en) Two-phase composition and its uses in cosmetics
US20040192832A1 (en) Transparent biphase composition for topical application
WO2022003000A1 (fr) Composition à deux phases comprenant un tensioactif alkylpolyglycoside, un diol particulier et un composé alcane, ester ou éther constitué de 15 à 30 atomes de carbone
US10773106B2 (en) Oil-in-water emulsion containing an amphiphilic polymer
WO2015091380A1 (fr) Composition à deux phases comprenant un dérivé d'acide cucurbique
ES2398747T3 (es) Composición en forma de una emulsión de aceite en agua que contiene un polímero anfifílico, y sus usos en particular en cosmética
WO2013160364A1 (fr) Composition comprenant un silane et un tensioactif gemini
Charbit et al. Two‐phase composition comprising a fatty acid ester of sugar or a liquid alkyl polyglucoside, with an HLB< 8, and a C8‐C18 branched alkane

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160128

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180103